D-Kimia Diagnostic Solutions
D-Kimia develops novel diagnostic solutions to detect a broad range of diseases by targeting the nucleic acid signature of the disease. Our diagnostic solutions are rapid, affordable, simple to use, and provide the same level of specificity as the most advanced Polymerase Chain Reaction (PCR), and other amplification- based diagnostic techniques.
Hepatitis C
Hepatitis C infects over 170 million people worldwide and continues to spread across the globe. D-Kimia’s patent pending platform has initially been optimized for the identification of the Hepatitis C virus. The platform provides rapid, accurate and affordable results without expensive and complicated lab equipment.
We aim to increase awareness and decrease the cost of testing to help contain the spread of the disease.